The company's shares are being delisted from the Nasdaq exchange tomorrow.
News & Analysis: MiMedx Group
A C-suite sweep and good news from a major market exchange lifted the troubled biotech stock.
The company announced product updates and earned an extension to remain listed on the Nasdaq exchange -- for now.
Find out which of these stocks fared the worst on an positive day for the market.
An insurer is saying it will no longer reimburse for the use of MiMedx products.
The biopharma is perilously close to being delisted from the Nasdaq stock exchange.
The hope that a C-suite shake-up and restated financials will put the company's worst days behind it are fueling a rally.
Can either of these drugmakers bounce back from recent troubles.
Find out which of these companies just replaced multiple high-level executives.
Traders flee after the company announces a massive shakeup in its executive suite. Here's what investors need to know.